News
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
Upstate Medical University on Monday, July 7 broke ground on a new, 109,000-square-foot clinical pathology laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback